Transformación de la Industria Gastronómica: Auge de Apps de Entrega en la Ciudad de Guayaquil
Revista Boaciencia. Negocios e Tecnología · 12.10.2022 · 2 (2) · 18-35
DOI: 10.59801/tyn.v2i2.214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Boaciencia. Negocios e Tecnología, online erschienen am 12.10.2022. Verfasst von Laura Martínez. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This project delves into the determining influence of factors in the adoption of food delivery app usage for purchasing fast food in Guayaquil, Ecuador. We investigate how delivery apps have become essential tools for fast food businesses, enabling them to sustain sales even under challenging circumstances like the COVID-19 pandemic. Initially obscure during the early moments of the pandemic, delivery apps gained prominence over time, propelled by collaborators offering home delivery services. Restaurants gradually began incorporating these tools to operate, as only app workers were permitted to move around during periods of exception. This study focuses on economically active individuals, a group representing potential consumers according to INEC data (2021), which indicates that 7.8 million Ecuadorians are employed and constitute a relevant population for this research.
Zitieren
APA
Martínez, L. (2022). Transformación de la Industria Gastronómica: Auge de Apps de Entrega en la Ciudad de Guayaquil. Revista Boaciencia. Negocios e Tecnología, 2(2), 18-35. https://doi.org/10.59801/tyn.v2i2.214
Vancouver
Martínez L. Transformación de la Industria Gastronómica: Auge de Apps de Entrega en la Ciudad de Guayaquil. Revista Boaciencia. Negocios e Tecnología. 2022;2(2):18-35. doi:10.59801/tyn.v2i2.214
BibTeX
@article{Martnez2022,
author = {Martínez, Laura},
title = {Transformación de la Industria Gastronómica: Auge de Apps de Entrega en la Ciudad de Guayaquil},
journal = {Revista Boaciencia. Negocios e Tecnología},
year = {2022},
volume = {2},
number = {2},
pages = {18--35},
doi = {10.59801/tyn.v2i2.214}
}
EUVIMED